Accelerate Diagnostics Inc (AXDX)
0.93
-0.02
(-1.62%)
USD |
NASDAQ |
Apr 26, 16:00
0.93
0.00 (0.00%)
After-Hours: 20:00
Accelerate Diagnostics Enterprise Value: 44.09M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 44.09M |
| April 24, 2024 | 43.78M |
| April 23, 2024 | 44.19M |
| April 22, 2024 | 42.83M |
| April 19, 2024 | 42.22M |
| April 18, 2024 | 40.29M |
| April 17, 2024 | 39.56M |
| April 16, 2024 | 41.28M |
| April 15, 2024 | 43.32M |
| April 12, 2024 | 42.85M |
| April 11, 2024 | 43.11M |
| April 10, 2024 | 42.89M |
| April 09, 2024 | 42.24M |
| April 08, 2024 | 43.47M |
| April 05, 2024 | 41.74M |
| April 04, 2024 | 41.80M |
| April 03, 2024 | 43.22M |
| April 02, 2024 | 43.98M |
| April 01, 2024 | 42.88M |
| March 28, 2024 | 45.06M |
| March 27, 2024 | 45.49M |
| March 26, 2024 | 44.41M |
| March 25, 2024 | 45.27M |
| March 22, 2024 | 43.68M |
| March 21, 2024 | 43.48M |
| Date | Value |
|---|---|
| March 20, 2024 | 43.68M |
| March 19, 2024 | 43.28M |
| March 18, 2024 | 43.47M |
| March 15, 2024 | 42.87M |
| March 14, 2024 | 43.88M |
| March 13, 2024 | 45.50M |
| March 12, 2024 | 44.89M |
| March 11, 2024 | 46.72M |
| March 08, 2024 | 46.92M |
| March 07, 2024 | 45.50M |
| March 06, 2024 | 45.91M |
| March 05, 2024 | 45.10M |
| March 04, 2024 | 44.49M |
| March 01, 2024 | 43.27M |
| February 29, 2024 | 43.58M |
| February 28, 2024 | 42.41M |
| February 27, 2024 | 42.06M |
| February 26, 2024 | 43.07M |
| February 23, 2024 | 43.27M |
| February 22, 2024 | 42.87M |
| February 21, 2024 | 46.72M |
| February 20, 2024 | 47.53M |
| February 16, 2024 | 47.53M |
| February 15, 2024 | 47.73M |
| February 14, 2024 | 48.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
39.56M
Minimum
Apr 17 2024
1.291B
Maximum
Jul 03 2019
442.34M
Average
433.35M
Median
Enterprise Value Benchmarks
| Achieve Life Sciences Inc | 157.87M |
| ENDRA Life Sciences Inc | -0.1293M |
| Tivic Health Systems Inc | -1.818M |
| Spectral AI Inc | 23.19M |
| Perspective Therapeutics Inc | 931.55M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.00M |
| Revenue (Quarterly) | 3.027M |
| Total Expenses (Quarterly) | 13.76M |
| EPS Diluted (Quarterly) | -0.81 |
| Gross Profit Margin (Quarterly) | 20.91% |
| Profit Margin (Quarterly) | -429.4% |
| Earnings Yield | -582.8% |
| Normalized Earnings Yield | -481.84 |